Cholinergic Mediation of Alcohol-induced Experimental Pancreatitis
Overview
Affiliations
Objectives: The mechanisms initiating pancreatitis in patients with chronic alcohol abuse are poorly understood. Although alcohol feeding has been previously suggested to alter cholinergic pathways, the effects of these cholinergic alterations in promoting pancreatitis have not been characterized. For this study, we determined the role of the cholinergic system in ethanol-induced sensitizing effects on cerulein pancreatitis.
Methods: Rats were pair-fed control and ethanol-containing Lieber-DeCarli diets for 6 weeks followed by parenteral administration of 4 hourly intraperitoneal injections of the cholecystokinin analog, cerulein at 0.5 μg/kg. This dose of cerulein was selected because it caused pancreatic injury in ethanol-fed but not in control-fed rats. Pancreatitis was preceded by treatment with the muscarinic receptor antagonist atropine or by bilateral subdiaphragmatic vagotomy. Measurement of pancreatic pathology included serum lipase activity, pancreatic trypsin, and caspase-3 activities, and markers of pancreatic necrosis, apoptosis, and autophagy. In addition, we measured the effects of ethanol feeding on pancreatic acetylcholinesterase activity and pancreatic levels of the muscarinic acetylcholine receptors m1 and m3. Finally, we examined the synergistic effects of ethanol and carbachol on inducing acinar cell damage.
Results: We found that atropine blocked almost completely pancreatic pathology caused by cerulein administration in ethanol-fed rats, while vagotomy was less effective. Ethanol feeding did not alter expression levels of cholinergic muscarinic receptors in the pancreas but significantly decreased pancreatic acetylcholinesterase activity, suggesting that acetylcholine levels and cholinergic input within the pancreas can be higher in ethanol-fed rats. We further found that ethanol treatment of pancreatic acinar cells augmented pancreatic injury responses caused by the cholinergic agonist, carbachol.
Conclusion: These results demonstrate key roles for the cholinergic system in the mechanisms of alcoholic pancreatitis.
Zhang J, Li C, Duan M, Qu Z, Wang Y, Dong Y Nutrients. 2025; 17(2).
PMID: 39861457 PMC: 11769147. DOI: 10.3390/nu17020320.
Shen Y, Duan H, Yuan L, Asikaer A, Liu Y, Zhang R Mol Divers. 2023; 28(4):2583-2601.
PMID: 37523101 DOI: 10.1007/s11030-023-10698-4.
Multiple roles for cholinergic signaling in pancreatic diseases.
Yang J, Yang X, Wan J World J Gastroenterol. 2022; 28(25):2910-2919.
PMID: 35978870 PMC: 9280742. DOI: 10.3748/wjg.v28.i25.2910.
Pancreas-specific CHRM3 activation causes pancreatitis in mice.
Wan J, Wang J, Wagner 2nd L, Wang O, Gui F, Chen J JCI Insight. 2021; 6(17).
PMID: 34314386 PMC: 8492327. DOI: 10.1172/jci.insight.132585.
Ketamine and xylazine effects in murine model of acute pancreatitis.
Wang M, Gorelick F Am J Physiol Gastrointest Liver Physiol. 2021; 320(6):G1111-G1122.
PMID: 33881355 PMC: 8285583. DOI: 10.1152/ajpgi.00023.2021.